The Race Is On: Faster Turnaround Times in the Diagnosis of Multidrug-Resistant Tuberculosis

In 2014, the Centers for Disease Control reported 9,412 new cases of tuberculosis (TB) – more than 9,000 too many! TB elimination is defined as 1 case per million population and with an estimated population in the United States (July 2014) of almost 319 million, this would result in only 319 cases – we have a long way to go in order to reach this ambitious goal.

In this webinar, Dr. Max Salfinger (National Jewish Health in Denver, Colorado) will provide an overview of the TB epidemic in the United States and abroad as well as the various molecular laboratory assays used to diagnose TB. Each laboratory plays an integral role in an overarching system comprised of health care providers, the laboratory community (hospital, commercial, public health and reference laboratories) and TB control.
Dr. Salfinger will answer questions from webinar attendees so be sure to attend and get answers from the expert!

What you will learn:
- An overview of the TB epidemic in the United States and abroad
- An understanding of the most important assays performed in TB research laboratories
- An understanding of the important role the laboratory plays in diagnosing TB

Speaker:
Max Salfinger M.D.
Director of the Mycobacteriology and
Pharmacokinetics Laboratories
National Jewish Health in Denver

Original Broadcast Date: December 10th, 2015

свернуть